NCT07224763: Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 50 planned
- Started
- Nov 2026
- Primary completion
- Nov 2029
- Arms
- GGTA1 KO Thymokidney
- Results
- None posted
- 5 Nov 2025: Trial registered